Lu‐Nan Qi
- Hepatology top 5%
- Oncology top 10%
- Cancer Research top 10%
- Molecular Biology
- Epidemiology
- Co-authors
- Bang‐De XiangLiang MaFeixiang WuJian‐Hong ZhongZu-Shun ChenZe‐Guang HanLe‐Qun LiWen‐Feng Gong
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (22 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers)Liver Disease Diagnosis and Treatment (9 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- ChinaBruneiUnited States
In The Last Decade
Lu‐Nan Qi
39 papers receiving 733 citations
Peers
Comparison fields: 5 of 73
- Hepatology 287
- Oncology 284
- Cancer Research 266
- Molecular Biology 178
- Epidemiology 172
Countries citing papers authored by Lu‐Nan Qi
This map shows the geographic impact of Lu‐Nan Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu‐Nan Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu‐Nan Qi more than expected).
Fields of papers citing papers by Lu‐Nan Qi
This network shows the impact of papers produced by Lu‐Nan Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu‐Nan Qi. The network helps show where Lu‐Nan Qi may publish in the future.
Co-authorship network of co-authors of Lu‐Nan Qi
This figure shows the co-authorship network connecting the top 25 collaborators of Lu‐Nan Qi. A scholar is included among the top collaborators of Lu‐Nan Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu‐Nan Qi. Lu‐Nan Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 6 | |
| 6 | 0 | |
| 7 | 12 | |
| 8 | 5 | |
| 9 | 10 | |
| 10 | 12 | |
| 11 | 9 | |
| 12 | 0 | |
| 13 | 226 | |
| 14 | 4 | |
| 15 | 42 | |
| 16 | 1 | |
| 17 | 10 | |
| 18 | 7 | |
| 19 | 35 | |
| 20 | 63 |
About Lu‐Nan Qi
Lu‐Nan Qi is a scholar working on Hepatology, Cancer Research and Oncology, having authored 41 papers that have together received 742 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). The work is most often cited by research in Hepatology (287 citations), Cancer Research (266 citations) and Oncology (284 citations). Lu‐Nan Qi has collaborated with scholars based in China, Brunei and United States. Frequent co-authors include Bang‐De Xiang, Liang Ma, Feixiang Wu, Jian‐Hong Zhong, Zu-Shun Chen, Ze‐Guang Han, Le‐Qun Li, Wen‐Feng Gong, Yuanyuan Chen and Jiazhou Ye. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.